Health

oi-Boldsky Desk


on January 15, 2022

There have been some media reports alleging vaccine shortage in Maharashtra, further stating that due to lack of vaccines the State Government is unable to increase the pace of vaccination in the state. Such reports are ill-informed and incorrect.

It is clarified that, as per the reports available today (14th January 2022), Maharashtra has over 24 lakh unutilized doses of Covaxin available with it. An additional 6.35 lakh doses have been received today. As per their weekly consumption data available on Co-WIN, the average consumption by Maharashtra for Covaxin to cover the eligible beneficiaries for 15-17 years and for precaution dose is almost 2.94 lakh doses per day. Therefore, the State has adequate vaccine doses for about 10 days to cover the eligible beneficiaries with Covaxin.

Furthermore, for Covishield, the state has 1.24 crore unutilized and balance doses available as of date. With an average consumption of 3.57 lakhs per day, this will sustain for more than 30 days for the beneficiaries to be vaccinated using the vaccine.

Hence, the media reports are not factually correct and do not reflect the correct picture of the available stock of balance and unutilized COVID vaccine doses with Maharashtra. (PIB)

GET THE BEST BOLDSKY STORIES!

Allow Notifications

You have already subscribed

Story first published: Saturday, January 15, 2022, 11:43 [IST]

Source:

You May Also Like

Subway Suddenly Cancels $6.99 Meal Deal—Here's Why

Like many of its fast-food rivals, Subway has tried to entice price-wary…

What Happens to Your Body When You Do Cardio Every Day

Cardio is a cornerstone of fitness, and performing it regularly can be…

5 Best Upper-Body Workouts for Men To Build Muscular Shoulders — Eat This Not That

Building well-defined, muscular shoulders requires a workout regimen that targets each part…

McDonald's Discontinued Its Grilled Chicken for a Reason, Ex-Chef Says

From Chicken McNuggets to McCrispy sandwiches, McDonald’s restaurants in the United States…